These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 14563342

  • 1. A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study.
    Freeman DJ, Samani NJ, Wilson V, McMahon AD, Braund PS, Cheng S, Caslake MJ, Packard CJ, Gaffney D.
    Eur Heart J; 2003 Oct; 24(20):1833-42. PubMed ID: 14563342
    [Abstract] [Full Text] [Related]

  • 2. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
    Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, Cambien F, Nicaud V, de Grooth GJ, Talmud PJ, Humphries SE, Miller GJ, Eiriksdottir G, Gudnason V, Kauma H, Kakko S, Savolainen MJ, Arca M, Montali A, Liu S, Lanz HJ, Zwinderman AH, Kuivenhoven JA, Kastelein JJ.
    Circulation; 2005 Jan 25; 111(3):278-87. PubMed ID: 15655129
    [Abstract] [Full Text] [Related]

  • 3. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
    de Grooth GJ, Zerba KE, Huang SP, Tsuchihashi Z, Kirchgessner T, Belder R, Vishnupad P, Hu B, Klerkx AH, Zwinderman AH, Jukema JW, Sacks FM, Kastelein JJ, Kuivenhoven JA.
    J Am Coll Cardiol; 2004 Mar 03; 43(5):854-7. PubMed ID: 14998629
    [Abstract] [Full Text] [Related]

  • 4. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.
    Liu S, Schmitz C, Stampfer MJ, Sacks F, Hennekens CH, Lindpaintner K, Ridker PM.
    Atherosclerosis; 2002 Apr 03; 161(2):469-74. PubMed ID: 11888533
    [Abstract] [Full Text] [Related]

  • 5. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.
    Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, Lie KI, Kastelein JJ.
    N Engl J Med; 1998 Jan 08; 338(2):86-93. PubMed ID: 9420339
    [Abstract] [Full Text] [Related]

  • 6. Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin.
    Marschang P, Sandhofer A, Ritsch A, Fiŝer I, Kvas E, Patsch JR.
    J Intern Med; 2006 Aug 08; 260(2):151-9. PubMed ID: 16882279
    [Abstract] [Full Text] [Related]

  • 7. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
    Dullaart RP, Hoogenberg K, Riemens SC, Groener JE, van Tol A, Sluiter WJ, Stulp BK.
    Diabetes; 1997 Dec 08; 46(12):2082-7. PubMed ID: 9392500
    [Abstract] [Full Text] [Related]

  • 8. Human cholestryl ester transfer protein (TaqIB) polymorphism among Filipinos with cardiovascular risk factors.
    Sy RG, Cutiongco EM, Punzalan FE, Santos RS, Geronimo FR, Tangco RV.
    J Atheroscler Thromb; 2007 Jun 08; 14(3):116-21. PubMed ID: 17587762
    [Abstract] [Full Text] [Related]

  • 9. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
    Brousseau ME, O'Connor JJ, Ordovas JM, Collins D, Otvos JD, Massov T, McNamara JR, Rubins HB, Robins SJ, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2002 Jul 01; 22(7):1148-54. PubMed ID: 12117730
    [Abstract] [Full Text] [Related]

  • 10. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.
    Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson PW, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2000 May 01; 20(5):1323-9. PubMed ID: 10807749
    [Abstract] [Full Text] [Related]

  • 11. HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients.
    Radeau T, Vohl MC, Houde I, Lachance JG, Noël R, Després JP, Douville P, Bergeron J.
    Nephron; 2000 Apr 01; 84(4):333-41. PubMed ID: 10754410
    [Abstract] [Full Text] [Related]

  • 12. Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort.
    Weitgasser R, Galvan G, Malaimare L, Derflinger I, Hedegger M, Lang J, Iglseder B, Ladurner G, Paulweber B.
    Biomed Pharmacother; 2004 Dec 01; 58(10):619-27. PubMed ID: 15589073
    [Abstract] [Full Text] [Related]

  • 13. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF, Muhlestein JB, Horne BD, Hart NI, Bair TL, Molhuizen HO, Anderson JL.
    Am Heart J; 2003 Dec 01; 146(6):1007-14. PubMed ID: 14660992
    [Abstract] [Full Text] [Related]

  • 14. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks.
    Hodoğlugil U, Williamson DW, Huang Y, Mahley RW.
    Clin Genet; 2005 Aug 01; 68(2):118-27. PubMed ID: 15996208
    [Abstract] [Full Text] [Related]

  • 15. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.
    Le Goff W, Guerin M, Nicaud V, Dachet C, Luc G, Arveiler D, Ruidavets JB, Evans A, Kee F, Morrison C, Chapman MJ, Thillet J.
    Atherosclerosis; 2002 Apr 01; 161(2):269-79. PubMed ID: 11888509
    [Abstract] [Full Text] [Related]

  • 16. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis.
    Arca M, Montali A, Ombres D, Battiloro E, Campagna F, Ricci G, Verna R.
    Clin Genet; 2001 Nov 01; 60(5):374-80. PubMed ID: 11903340
    [Abstract] [Full Text] [Related]

  • 17. The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans.
    Park KW, Choi JH, Kim HK, Oh S, Chae IH, Kim HS, Oh BH, Lee MM, Park YB, Choi YS.
    Clin Genet; 2003 Jan 01; 63(1):31-8. PubMed ID: 12519369
    [Abstract] [Full Text] [Related]

  • 18. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population.
    Corella D, Sáiz C, Guillén M, Portolés O, Mulet F, González JI, Ordovás JM.
    Atherosclerosis; 2000 Oct 01; 152(2):367-76. PubMed ID: 10998464
    [Abstract] [Full Text] [Related]

  • 19. The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men.
    Eiriksdottir G, Bolla MK, Thorsson B, Sigurdsson G, Humphries SE, Gudnason V.
    Atherosclerosis; 2001 Nov 01; 159(1):187-92. PubMed ID: 11689220
    [Abstract] [Full Text] [Related]

  • 20. Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).
    Klerkx AH, de Grooth GJ, Zwinderman AH, Jukema JW, Kuivenhoven JA, Kastelein JJ.
    Eur J Clin Invest; 2004 Jan 01; 34(1):21-8. PubMed ID: 14984434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.